Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin
Clinical trial NCT00039962 · COMPLETED
Trial details
- NCT number
- NCT00039962
- Sponsor
- SciClone Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.